This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Michael Coiley, Managing Director Of CIT Healthcare (Photo: Business Wire)

Stocks in this article: CIT

CIT Group Inc. (NYSE: CIT) cit.com, a leading provider of financing to small businesses and middle market companies, today announced that CIT Healthcare served as Sole Lead Arranger in a $15.5 million senior secured credit facility to DeVilbiss Healthcare, a medical device company and a portfolio company of Vestar Capital Partners, a leading private equity firm specializing in middle market growth capital investments.

Michael Coiley, Managing Director of CIT Healthcare (Photo: Business Wire)

Michael Coiley, Managing Director of CIT Healthcare (Photo: Business Wire)

The financing was provided by CIT Bank, a wholly-owned subsidiary of CIT. Terms of the transaction were not disclosed. Proceeds of the facility will be used for refinancing debt, for working capital and for new equipment purchases.

“This transaction highlights our expertise and experience in working with private equity firms to meet the financing needs of their middle market healthcare portfolio companies,” said Michael Coiley, Managing Director of CIT Healthcare. “We are pleased to have provided this financing, which will allow DeVilbiss Healthcare to grow their business.”

Ed Murphy, CEO of DeVilbiss Healthcare, commented, “CIT presented a tailored financing structure that met our goals and will allow us to continue to invest in manufacturing and product development. This deal positions us well for future growth and will help create 20 new jobs in Pennsylvania. We look forward to building on our relationship with CIT.

Chris Durbin, Managing Director at Vestar Capital Partners, said, “For more than two decades, we have worked with talented management teams to grow their businesses. This financing will allow DeVilbiss Healthcare to continue to grow as it develops products that meet the respiratory needs of patients in institutional and homecare settings throughout the world.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs